Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision tag was updated to v3.6.4, replacing the previous v3.6.3 as part of an internal revision history update.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.0, indicating an updated internal build of the study details page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now displays that recruitment is closed with a 'No longer looking for participants' notice. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a minor formatting change was made to the Interventions label (Intervention / Treatment → Intervention/Treatment) along with a revision version update from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page version was updated from v3.5.4 to v3.5.5. This appears to be a minor maintenance update to the page.SummaryDifference0.0%

- Check74 days agoChange DetectedA new reference to a 2025 publication by Cummings et al. evaluating cognitive, functional, and behavioral effects observed in EMERGE (the aducanumab Phase 3 trial) was added to the Publications section.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a minor update to the page.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.